{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:37:07Z","timestamp":1788907027270,"version":"build-2803163510"},"reference-count":20,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Data suggest that the opioid crisis in North America has recently been reflected in opioid-related mortality among youths. Despite recommendation for its use, youths encounter barriers to accessing OAT, including stigma, burden of witnessed dosing, and lack of availability of youth-oriented services and prescribers comfortable treating this population.<\/jats:p><\/jats:sec>Objective<\/jats:title>To compare rates of opioid agonist treatment (OAT) and opioid-related mortality between youths aged 15 to 24 years and adults aged 25 to 44 years in Ontario, Canada, over time.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This cross-sectional analysis of rates of OAT and opioid-related deaths between 2013 and 2021 used data obtained from the Ontario Drug Policy Research Network, Public Health Ontario, and Statistics Canada. Individuals included in the analysis were aged 15 to 44 years and residing in Ontario, the most populous province in Canada.<\/jats:p><\/jats:sec>Exposures<\/jats:title>Youths aged 15 to 24 years compared with adults aged 25 to 44 years.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>OAT (methadone, buprenorphine, and slow-release oral morphine) per 1000 population and opioid-related deaths per 100\u202f000 population.<\/jats:p><\/jats:sec>Results<\/jats:title>Between 2013 and 2021, 1021 youths aged 15 to 24 years died from opioid toxicity; 710 were male (69.5%). In the final year of the study period, 225 youths (146 male [64.9%]) died from opioid toxicity, and 2717 (1494 male [55.0%]) were dispensed OAT. Over the study period, the rate of opioid-related deaths among youths in Ontario increased 369.2% from 2.6 to 12.2 per 100\u202f000 population (48 to 225 total deaths) and the rate of OAT use decreased 55.9% from 3.4 to 1.5 per 1000 (6236 to 2717 individuals). For adults aged 25 to 44 years, the rate of opioid-related deaths increased 371.8% from 7.8 to 36.8 per 100\u202f000 (283 to 1502 deaths), and the rate of OAT increased 27.8% from 7.9 to 10.1 per 1000 population (28\u202f667 to 41\u202f200 individuals). Trends for youths and adults persisted across both sexes.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>The findings of this study suggest that opioid-related deaths are increasing among youths while OAT use is paradoxically declining. The reasons for these observed trends require further investigation, including a consideration of changing trends in opioid use and opioid use disorder among youths, barriers to OAT, and opportunities to optimize care and reduce harms for youths who use substances.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2023.21947","type":"journal-article","created":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:32:22Z","timestamp":1688657542000},"page":"e2321947","source":"Crossref","is-referenced-by-count":12,"title":["Trends in Rates of Opioid Agonist Treatment and Opioid-Related Deaths for Youths in Ontario, Canada, 2013-2021"],"prefix":"10.1001","volume":"6","author":[{"given":"Tea","family":"Rosic","sequence":"first","affiliation":[{"name":"Department of Psychiatry, University of Ottawa, Ottawa, Ontario, Canada"},{"name":"Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Kolla","sequence":"additional","affiliation":[{"name":"Canadian Institute for Substance Use Research, University of Victoria, Victoria, British Columbia, Canada"},{"name":"Unity Health Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Leece","sequence":"additional","affiliation":[{"name":"Public Health Ontario, Toronto, Ontario, Canada"},{"name":"Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada"},{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Kitchen","sequence":"additional","affiliation":[{"name":"ICES, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Gomes","sequence":"additional","affiliation":[{"name":"Unity Health Toronto, Toronto, Ontario, Canada"},{"name":"ICES, Toronto, Ontario, Canada"},{"name":"Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada"},{"name":"Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2023,7,6]]},"reference":[{"issue":"5","key":"zoi230649r1","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1097\/ADM.0000000000000412","article-title":"Measuring the burden of opioid-related mortality in Ontario, Canada.","volume":"12","author":"Gomes","year":"2018","journal-title":"J Addict Med"},{"issue":"14","key":"zoi230649r2","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1001\/jama.2022.2847","article-title":"Trends in drug overdose deaths among US adolescents, January 2010 to June 2021.","volume":"327","author":"Friedman","year":"2022","journal-title":"JAMA"},{"issue":"3","key":"zoi230649r3","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-assisted treatment of adolescents with opioid use disorders.","volume":"138","author":"Committee On Substance Use And Prevention","year":"2016","journal-title":"Pediatrics"},{"issue":"8","key":"zoi230649r4","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014.","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"11","key":"zoi230649r5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder.","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatr"},{"key":"zoi230649r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103773","article-title":"Navigating opioid agonist therapy among young people who use illicit opioids in Vancouver, Canada.","volume":"107","author":"Pilarinos","year":"2022","journal-title":"Int J Drug Policy"},{"issue":"4","key":"zoi230649r10","doi-asserted-by":"publisher","first-page":"E67","DOI":"10.1503\/cmaj.150349","article-title":"Sensitivity and specificity of administrative mortality data for identifying prescription opioid-related deaths.","volume":"188","author":"Gladstone","year":"2016","journal-title":"CMAJ"},{"issue":"6","key":"zoi230649r12","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/ADM.0000000000000348","article-title":"Addressing stigma in medication treatment of adolescents with opioid use disorder.","volume":"11","author":"Bagley","year":"2017","journal-title":"J Addict Med"},{"issue":"1","key":"zoi230649r13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s13722-018-0116-2","article-title":"Stigma associated with medication treatment for young adults with opioid use disorder: a case series.","volume":"13","author":"Hadland","year":"2018","journal-title":"Addict Sci Clin Pract"},{"issue":"6","key":"zoi230649r14","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder.","volume":"60","author":"Feder","year":"2017","journal-title":"J Adolesc Health"},{"key":"zoi230649r15","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/1471-244X-10-113","article-title":"Perceived barriers and facilitators to mental health help-seeking in young people: a systematic review.","volume":"10","author":"Gulliver","year":"2010","journal-title":"BMC Psychiatry"},{"issue":"5","key":"zoi230649r16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jadohealth.2016.11.019","article-title":"A review of effective youth engagement strategies for mental health and substance use interventions.","volume":"60","author":"Dunne","year":"2017","journal-title":"J Adolesc Health"},{"key":"zoi230649r18","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugpo.2022.103680","article-title":"Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions.","volume":"104","author":"Bouck","year":"2022","journal-title":"Int J Drug Policy"},{"key":"zoi230649r19","doi-asserted-by":"publisher","DOI":"10.1016\/j.josat.2023.209029","article-title":"Impact of changes to the delivery of opioid agonist treatment, introduced during the COVID-19 pandemic, on treatment access and dropout in Ireland: an interrupted time series analysis.","volume":"149","author":"Durand","year":"2023","journal-title":"J Subst Use Addict Treat"},{"issue":"9","key":"zoi230649r20","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1001\/jama.2022.1271","article-title":"Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation.","volume":"327","author":"Gomes","year":"2022","journal-title":"JAMA"},{"key":"zoi230649r7","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario) Toronto. Interactive opioid tool: opioid-related morbidity and mortality in Ontario. Updated March 31, 2023. Accessed March 8, 2023. https:\/\/www.publichealthontario.ca\/en\/data-and-analysis\/substance-use\/interactive-opioid-tool"},{"key":"zoi230649r8","unstructured":"Ontario Agency for Health Protection and Promotion (Public Health Ontario). Technical notes: interactive opioid tool\u20135th revision. March 2023. Accessed March 8, 2023. https:\/\/www.publichealthontario.ca\/-\/media\/documents\/O\/2018\/opioid-tool-technical-notes.pdf"},{"key":"zoi230649r9","unstructured":"Gomes? T, Murray? R, Kolla? G, ; Ontario Drug Policy Research Network, Office of the Chief Coroner for Ontario and Ontario Agency for Health Protection and Promotion. Changing circumstances surrounding opioid-related deaths in Ontario during the COVID-19 pandemic. May 2021. Accessed March 8, 2023. https:\/\/odprn.ca\/wp-content\/uploads\/2021\/05\/Changing-Circumstances-Surrounding-Opioid-Related-Deaths.pdf"},{"key":"zoi230649r11","unstructured":"Statistics Canada. Table 17-10-0005-01. Population estimates on July 1st, by age and sex. December 21, 2022. Accessed July 11, 2022. https:\/\/www150.statcan.gc.ca\/t1\/tbl1\/en\/tv.action?pid=1710000501"},{"key":"zoi230649r17","unstructured":"Boak? A, Elton-Marshall? T, Mann? RE, Hamilton? HA. Drug Use Among Ontario Students, 1977-2019: Detailed Findings From the Ontario Student Drug Use and Health Survey (OSDUHS). Centre for Addiction and Mental Health. Published online 2020. Accessed March 8, 2023. https:\/\/www.camh.ca\/-\/media\/files\/pdf---osduhs\/drugusereport_2019osduhs-pdf.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2806862\/rosic_2023_oi_230649_1687894975.24692.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,6]],"date-time":"2023-07-06T15:32:29Z","timestamp":1688657549000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2806862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,6]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.21947","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,6]]}}}